skip to main content
Idioma:
Refinado por: assunto: Care And Treatment remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Poulain, L ; Sujobert, P ; Zylbersztejn, F ; Barreau, S ; Stuani, L ; Lambert, M ; Palama, T L ; Chesnais, V ; Birsen, R ; Vergez, F ; Farge, T ; Chenevier-Gobeaux, C ; Fraisse, M ; Bouillaud, F ; Debeissat, C ; Herault, O ; Récher, C ; Lacombe, C ; Fontenay, M ; Mayeux, P ; Maciel, T T ; Portais, J-C ; Sarry, J-E ; Tamburini, J ; Bouscary, D ; Chapuis, N

Leukemia, 2017-11, Vol.31 (11), p.2326-2335 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling
Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

Kerdivel, G ; Chesnais, V ; Becht, E ; Toma, A ; Cagnard, N ; Dumont, F ; Rousseau, A ; Fenaux, P ; Chevret, S ; Chapuis, N ; Boeva, V ; Fridman, W H ; Fontenay, M ; Kosmider, O

Leukemia, 2018-02, Vol.32 (2), p.558-562 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)

Sardnal, V ; Rouquette, A ; Kaltenbach, S ; Bally, C ; Chesnais, V ; Leschi, C ; Ades, L ; Santini, V ; Park, S ; Toma, A ; Fenaux, P ; Dreyfus, F ; Fontenay, M ; Kosmider, O

Leukemia, 2013-07, Vol.27 (7), p.1610-1613 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Association of genetic polymorphisms related to Johne's disease with estimated breeding values of Holstein sires for milk ELISA test scores
Association of genetic polymorphisms related to Johne's disease with estimated breeding values of Holstein sires for milk ELISA test scores
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of genetic polymorphisms related to Johne's disease with estimated breeding values of Holstein sires for milk ELISA test scores

Mallikarjunappa, Sanjay ; Schenkel, Flavio S ; Brito, Luiz F ; Bissonnette, Nathalie ; Miglior, Filippo ; Chesnais, Jacques ; Lohuis, Michael ; Meade, Kieran G ; Karrow, Niel A

BMC veterinary research, 2020-05, Vol.16 (1), p.165-165, Article 165 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.